Risen MD

BPC-157 + TB-500 · Compounded

Two prescribed peptides, one clinical review, ongoing care.

BPC-157 and TB-500 together, prescribed by a licensed U.S. provider after a clinical review and prepared for you by a licensed U.S. compounding pharmacy, with follow-up from your care team.

$197/mo · $591 for 90 daysShipping and cold-chain included. Prepaid multi-month pricing is locked at purchase.

Compounded medications are prepared by licensed U.S. compounding pharmacies for an individual patient under a prescription. They are not approved by the FDA and have not been evaluated by the FDA for safety, effectiveness, or quality.

You are only charged for medication if a licensed provider writes a prescription for you.

Join the WaitlistCheckout opens at launch. Eligibility is determined by a licensed provider after an evaluation.

Risen MD is your covered entity; intake runs on a HIPAA-compliant, BAA-backed platform.

How it works

Three steps, every program.

The clinical review is never skipped, whatever you come here for.

  1. Intake.A private form inside a secure, HIPAA-compliant platform.
  2. Licensed-provider review.A licensed U.S. provider evaluates your intake and decides on treatment, which is never guaranteed.
  3. Ongoing care.If prescribed, medication ships from a licensed U.S. pharmacy and your care team follows up.

What is in this program

One peptide therapy program with two peptides.

Wolverine Recovery is one prescribed formulation containing two peptides: TB-500 and BPC-157. TB-500 is the one that makes this program different from a single-peptide one, so it is described first below.

Because neither peptide is FDA-approved, there is no approved labeling for us to quote — so this page does not state what either one will do for you. That is a deliberate choice rather than an omission: a statement about what a treatment will do belongs to the licensed provider who has read your history, and to nobody else.

What the combination changes on this side of the intake, we can be exact about: one prescription rather than two, one clinical review, one price per term, one shipment carrying both peptides, and a care team following up on the program as a whole. Whether two peptides is right for you is a clinical judgement your provider makes — not an upgrade you buy for a better outcome. Ask your provider what the combination is intended to do in your case.

The second peptide — the difference

TB-500

A synthetic peptide based on a fragment of thymosin beta-4, a protein that occurs naturally in human tissue. Prescription-only, prepared for one named patient by a licensed U.S. compounding pharmacy, and not FDA-approved.

TB-500 is not offered on its own here. It is included only in this combined program, which is why this is the only page that describes it.

The base peptide — also its own program

BPC-157

A synthetic peptide based on a sequence found in human gastric juice. Prescription-only, prepared for one named patient by a licensed U.S. compounding pharmacy, and not FDA-approved.

The same peptide is also offered on its own, as a single-peptide program at its own price. That page carries the full detail if you want to compare before your intake.

See the BPC-157 program →

Evidence and sources

What the sources say.

Every clinical statement on this page carries its source and the date it was last reviewed.

Safety and candor

Not for everyone — and that is the point of the review.

Compounded medications are prepared by licensed U.S. compounding pharmacies for an individual patient under a prescription. They are not approved by the FDA and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded medications have not been evaluated by the FDA for safety or effectiveness.

Not for people with

  • Pregnancy, planning pregnancy, or breastfeeding
  • Active cancer or a history of cancer (discuss with your provider)
  • Known hypersensitivity to the formulation

Treatment, prescriptions, and eligibility are determined by a licensed provider following an evaluation, and are never guaranteed.

FAQ

Questions

Is this FDA-approved?

No. Compounded medications are prepared for an individual patient under a prescription and are not FDA-approved. A licensed provider decides whether this program is appropriate for you.

Should I choose this or BPC-157 alone?

That is a clinical decision, not a product tier. A licensed provider reviews your intake and history and determines which — if either — is appropriate. This program costs more because it contains a second prescribed peptide, not because it is a premium version of the same treatment.

Clinical oversightLicensed U.S. providers review every intake. Treatment decisions are theirs, made after an evaluation.
Pharmacy networkLicensed U.S. compounding pharmacies, primary and backup, prepare compounded medications under a prescription.
Cash-pay clarityNot insurance. ID verification before treatment. One price per program and term, shown before you pay.
Private and discreetDiscreet packaging. Your care runs inside a secure portal, not over this website.

Join the waitlist

We will email you when your program is available in your state. No health information is collected here.